Decreased serum TSH levels are not associated with mortality in the adult northeast German population

European Journal of Endocrinology

Volumn 162, Issue 3, 2010, Pages 579-585

  Ittermann, Till ^a   Haring, Robin ^a   Sauer, Sybille ^a   Wallaschofski, Henri ^a   Dörr, Marcus ^a   Nauck, Matthias ^a   Völzke, Henry ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GERMANY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SUBCLINICAL HYPERTHYROIDISM; SURVIVAL TIME; THYROID DISEASE; THYROTROPIN BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; THYROID DISEASES; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 77149169720     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0566     Document Type: Article

References (35)

1. Volzke H, Robinson DM, Schminke U, Ludemann J, Rettig R, Felix SB, Kessler C, John U & Meng W. Thyroid function and carotid wall thickness. Journal of Clinical Endocrinology and Metabolism 2004 89 2145-2149.
2. Auer J, Scheibner P, Mische T, Langsteger W, Eber O & Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. American Heart Journal 2001 142 838-842.
3. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP & Ladenson PW. Thyroid status, cardiovascular risk, and mortality in older adults. Journal of the American Medical Association 2006 295 1033-1041.
4. Dorr M, Robinson DM, Wallaschofski H, Schwahn C, John U, Felix SB & Volzke H. Low serum thyrotropin is associated with high plasma fibrinogen. Journal of Clinical Endocrinology and Metabolism 2006 91 530-534.
5. Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Sacca L, Filetti S, Lombardi G & Perticone F. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. Journal of Clinical Endocrinology and Metabolism 2000 85 4701-4705.
6. Dorr M, Wolff B, Robinson DM, John U, Ludemann J, Meng W, Felix SB & Volzke H. The association of thyroid function with cardiac mass and left ventricular hypertrophy. Journal of Clinical Endocrinology and Metabolism 2005 90 673-677.
7. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frolich M & Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. Journal of the American Medical Association 2004 292 2591-2599.
8. Haentjens P, Van Meerhaeghe A, Poppe K & Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. European Journal of Endocrinology 2008 159 343-345.
9. Iervasi G, Molinaro S, Landi P, Taddei MC, Galli E, Mariani F, L'Abbate A & Pingitore A. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Archives of Internal Medicine 2007 167 1526-1532.
10. Ochs N, Auer R, Bauer DC, Nanchen D, Gussekloo J, Cornuz J & Rodondi N. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Annals of Internal Medicine 2008 148 832-845.
11. Osman F, Franklyn JA, Holder RL, Sheppard MC & Gammage MD. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case - control study. Journal of the American College of Cardiology 2007 49 71-81.
12. Parle JV, Maisonneuve P, Sheppard MC, Boyle P & Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001 358 861-865.
13. Radacsi A, Kovacs G, Bernard W, Feldkamp J, Horster FA & Szabolcs I. Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr followup study. Endocrine 2003 21 133-136.
14. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP & Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. International Journal of Cardiology 2008 125 41-48.
15. van den Beld AW, Visser TJ, Feelders RA, Grobbee DE & Lamberts SW. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. Journal of Clinical Endocrinology and Metabolism 2005 90 6403-6409.
16. Volzke H, Menzel D, Henzler J, Robinson D, Motz W, Rettig R & Dorr M. Serum thyrotropin levels predict all-cause and circulatory mortality in patients with invasively treated coronary artery disease. International Journal of Cardiology 2008 133 407-410.
17. Volzke H, Schwahn C, Wallaschofski H & Dorr M. Review: the association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? Journal of Clinical Endocrinology and Metabolism 2007 92 2421-2429.
18. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P & Michelangeli V. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Archives of Internal Medicine 2005 165 2467-2472.
19. Flynn RW, Macdonald TM, Jung RT, Morris AD & Leese GP. Mortality and vascular outcomes in patients treated for thyroid dysfunction. Journal of Clinical Endocrinology and Metabolism 2006 91 2159-2164.
20. Franklyn JA, Maisonneuve P, Sheppard M, Betteridge J & Boyle P. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study. Lancet 1999 353 2111-2115.
21. Goldman MB, Monson RR & Maloof F. Cancer mortality in women with thyroid disease. Cancer Research 1990 50 2283-2289.
22. Hall P, Berg G, Bjelkengren G, Boice JD Jr, Ericsson UB, Hallquist A, Lidberg M, Lundell G, Tennvall J, Wiklund K & Holm LE. Cancer mortality after iodine-131 therapy for hyperthyroidism. International Journal of Cancer 1992 50 886-890.
23. Hoffman DA, McConahey WM, Fraumeni JF Jr & Kurland LT. Cancer incidence following treatment of hyperthyroidism. International Journal of Epidemiology 1982 11 218-224.
24. Metso S, Jaatinen P, Huhtala H, Auvinen A, Oksala H & Salmi J. Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. Journal of Clinical Endocrinology and Metabolism 2007 92 2190-2196.
25. John U, Greiner B, Hensel E, Lüdemann J, Piek M, Sauer S, Adam C, Born G, Alte D, Greiser E, Haertel U, Hense HW, Haerting J, Willich S & Kessler C. Study of Health in Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Sozial- und Präventivmedizin 2001 46 186-194.
26. Völzke H, Lüdemann J, Robinson DM, Spieker KW, Schwahn C, Kramer A, John U & Meng W. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003 13 803-810.
27. Volzke H, Alte D, Kohlmann T, Ludemann J, Nauck M, John U & Meng W. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005 15 279-285.
28. Clauss A. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematologica 1957 17 237-246.
29. von Elm E, Altman D, Egger M, Pocock S, Gøtzsche P & Vandenbroucke J. STROBE initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Annals of Internal Medicine 2007 147 573-577.
30. Chubb SA, Davis WA & Davis TM. Subclinical hypothyroidism and mortality in women with type 2 diabetes. Clinical Endocrinology 2006 64 476-477.
31. Knudsen N, Laurberg P, Perrild H, Bulow I, Ovesen L & Jorgensen T. Risk factors for goiter and thyroid nodules. Thyroid 2002 12 879-888.
32. Völzke H, Schwahn C, Kohlmann T, Kramer A, Robinson DM, John U & Meng W. Risk factors for goiter in a previously iodinedeficient region. Experimental and Clinical Endocrinology and Diabetes 2005 113 507-515.
33. Kannel WB & Higgins M. Smoking and hypertension as predictors of cardiovascular risk in population studies. Journal of Hypertension. Supplement 1990 8 S3-S8.
34. Stewart S, Hart CL, Hole DJ & McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year followup of the Renfrew/Paisley study. American Journal of Medicine 2002 113 359-364.
35. Brabant G, Beck-Peccoz P, Jarzab B, Laurberg P, Orgiazzi J, Szabolcs I, Weetman AP & Wiersinga WM. Is there a need to redefine the upper normal limit of TSH? European Journal of Endocrinology 2006 154 633-637.